Abingdon Health announces the appointment of Mary Tavener as Non-Executive Director (NED) and Board member with immediate effect. Mary will be the Senior Independent NED of Abingdon Health and Chair of the Audit Committee.
Abingdon Health announces new non-executive director and board member
Mary has extensive experience in the healthcare sector, having previously been Chief Financial Officer and Board member of AIM listed Advanced Medical Solutions plc (AMS) for 19 years during which the company saw 15 years of consecutive growth. At AMS, Mary was responsible for strategy and risk management, finance, operations, regulatory, and legal affairs. Mary is a Member of the Chartered Institute of Management Accountants (ACMA) and a Fellow of the Association of Corporate Treasurers (FCT). She has a degree in Chemistry from the University of Oxford. Mary is also a NED and Chair of the Audit Committee of Allergy Therapeutics plc.
Dr Chris Hand, Chairman of Abingdon Health, said: “I’m delighted to welcome Mary Tavener to the board of Abingdon Health. Mary’s breadth of experience in the healthcare sector, and her finance expertise will make an invaluable addition to our board as we continue to significantly expand our operations. We are delighted that Mary will be working with us and I look forward to working with her and my colleagues as we continue to build scale at Abingdon”.
Tavener added: “I am pleased to have been invited to join the Board of Abingdon Health and look forward to working with Board members at the time of significant growth for the company. This is an exciting time for the Company as it expands manufacturing scale to provide solutions to diagnostic testing for COVID-19 alongside other diagnostic applications for its lateral flow technology.”